Sponsor Pipeline

Xinhong Wu, PhD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07130643 Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2… HR+/HER2- Breast Cancer Active, Not Recruiting
Disease Areas
Breast Cancer (1)
Get alerts when Xinhong Wu, PhD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free